» Articles » PMID: 16782877

Mechanisms Directing the Nuclear Localization of the CtBP Family Proteins

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2006 Jun 20
PMID 16782877
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The C-terminal binding protein (CtBP) family includes four proteins (CtBP1 [CtBP1-L], CtBP3/BARS [CtBP1-S], CtBP2, and RIBEYE) which are implicated both in transcriptional repression and in intracellular trafficking. However, the precise mechanisms by which different CtBP proteins are targeted to different subcellular regions remains unknown. Here, we report that the nuclear import of the various CtBP proteins and splice isoforms is differentially regulated. We show that CtBP2 contains a unique nuclear localization signal (NLS) located within its N-terminal region, which contributes to its nuclear accumulation. Using heterokaryon assays, we show that CtBP2 is capable of shuttling between the nucleus and cytoplasm of the cell. Moreover, CtBP2 can heterodimerize with CtBP1-L and CtBP1-S and direct them to the nucleus. This effect strongly depends on the CtBP2 NLS. PXDLS motif-containing transcription factors, such as BKLF, that bind CtBP proteins can also direct them to the nucleus. We also report the identification of a splice isoform of CtBP2, CtBP2-S, that lacks the N-terminal NLS and localizes to the cytoplasm. Finally, we show that mutation of the CtBP NADH binding site impairs the ability of the proteins to dimerize and to associate with BKLF. This reduces the nuclear accumulation of CtBP1. Our results suggest a model in which the nuclear localization of CtBP proteins is influenced by the CtBP2 NLS, by binding to PXDLS motif partner proteins, and through the effect of NADH on CtBP dimerization.

Citing Articles

CtBP1 is essential for epigenetic silencing of μ-opioid receptor genes in the dorsal root ganglion in spinal nerve ligation-induced neuropathic pain.

Lai C, Hsieh M, Yeh C, Lin T, Chou D, Wang H Neurotherapeutics. 2024; 22(1):e00493.

PMID: 39580324 PMC: 11743074. DOI: 10.1016/j.neurot.2024.e00493.


Genetic and functional analyses of CTBP2 in anorexia nervosa and body weight regulation.

Giuranna J, Zheng Y, Brandt M, Jall S, Mukherjee A, Shankhwar S Mol Psychiatry. 2024; .

PMID: 39511451 DOI: 10.1038/s41380-024-02791-3.


Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis.

Zhang T, Li S, Tan Y, Chen X, Zhang C, Chen Z Cancer Lett. 2024; 604:217240.

PMID: 39265800 PMC: 11471366. DOI: 10.1016/j.canlet.2024.217240.


Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.

Filograna A, De Tito S, Monte M, Oliva R, Bruzzese F, Roca M J Exp Clin Cancer Res. 2024; 43(1):137.

PMID: 38711119 PMC: 11071220. DOI: 10.1186/s13046-024-03044-5.


CtBP Neuroprotective Role in Toxin-Based Parkinson's Disease Models: From Expression Pattern to Dopaminergic Survival.

Saraiva C, Lopes-Nunes J, Esteves M, Santos T, Vale A, Cristovao A Mol Neurobiol. 2023; 60(8):4246-4260.

PMID: 37060501 PMC: 10293336. DOI: 10.1007/s12035-023-03331-w.


References
1.
Thio S, Bonventre J, Hsu S . The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain. Nucleic Acids Res. 2004; 32(5):1836-47. PMC: 390340. DOI: 10.1093/nar/gkh344. View

2.
Chinnadurai G . CtBP family proteins: more than transcriptional corepressors. Bioessays. 2003; 25(1):9-12. DOI: 10.1002/bies.10212. View

3.
Deltour S, Pinte S, Guerardel C, Wasylyk B, Leprince D . The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol Cell Biol. 2002; 22(13):4890-901. PMC: 133903. DOI: 10.1128/MCB.22.13.4890-4901.2002. View

4.
Barnes C, Vadlamudi R, Mishra S, Jacobson R, Li F, Kumar R . Functional inactivation of a transcriptional corepressor by a signaling kinase. Nat Struct Biol. 2003; 10(8):622-8. DOI: 10.1038/nsb957. View

5.
Turner J, Nicholas H, Bishop D, Matthews J, Crossley M . The LIM protein FHL3 binds basic Krüppel-like factor/Krüppel-like factor 3 and its co-repressor C-terminal-binding protein 2. J Biol Chem. 2003; 278(15):12786-95. DOI: 10.1074/jbc.M300587200. View